The emerging role of exosomes in mental disorders

Exosomes are a class of extracellular vesicles of endocytic origin, which are released by cells and are accessible in biofluids, such as saliva, urine, and plasma. These vesicles are enriched with small RNA, and they play a role in many physiological processes. In the brain, they are involved in processes including synaptic plasticity, neuronal stress response, cell-to-cell communication and neurogenesis. While exosomes have been implicated previously in cancer and neurodegenerative diseases, research regarding their role in mental disorders remains scarce. Given their functional significance in the brain, investigation in this field is warranted. Additionally, because exosomes can cross the blood–brain barrier, they may serve as accessible biomarkers of neural dysfunction. Studying exosomes may provide information towards diagnosis and therapeutic intervention, and specifically those derived from the brain may provide a mechanistic view of the disease phenotype. This review will discuss the roles of exosomes in the brain, and relate novel findings to current insights into mental disorders.

[1]  I. Sargent,et al.  Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing , 2014, Journal of thrombosis and haemostasis : JTH.

[2]  Takahiro A. Kato,et al.  Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: An exploratory pilot case-control study. , 2018, Journal of affective disorders.

[3]  Appearance of claudin-5+ leukocytes in the central nervous system during neuroinflammation: a novel role for endothelial-derived extracellular vesicles , 2016, Journal of Neuroinflammation.

[4]  T. Vu,et al.  Quantitative analysis of multivesicular bodies (MVBs) in the hypoglossal nerve: Evidence that neurotrophic factors do not use MVBs for retrograde axonal transport , 2009, The Journal of comparative neurology.

[5]  C. Hammen Stress and depression. , 2005, Annual review of clinical psychology.

[6]  T. J. Cook,et al.  Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease , 2014, Acta Neuropathologica.

[7]  Dongmei Sun,et al.  Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  M. Cairns,et al.  Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. , 2008, Human molecular genetics.

[9]  V. Costa,et al.  The Multifaceted Role of Annexin A1 in Viral Infections , 2023, Cells.

[10]  Sidney L. Jackson Review of Current Research , 1966 .

[11]  L. Lannfelt,et al.  Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers , 2018, Acta Neuropathologica.

[12]  U. Wyneken,et al.  Small Extracellular Vesicles in Rat Serum Contain Astrocyte-Derived Protein Biomarkers of Repetitive Stress , 2018, The international journal of neuropsychopharmacology.

[13]  R. Coffey,et al.  Proteomic Analysis of Exosomes from Mutant KRAS Colon Cancer Cells Identifies Intercellular Transfer of Mutant KRAS* , 2012, Molecular & Cellular Proteomics.

[14]  G. Fond,et al.  Inflammation in psychiatric disorders , 2014, European Psychiatry.

[15]  D. Kupfer,et al.  Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report , 2006 .

[16]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[17]  A. Khvorova,et al.  High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources , 2016, Journal of extracellular vesicles.

[18]  A. Buchan,et al.  Circulating endothelial cell-derived extracellular vesicles mediate the acute phase response and sickness behaviour associated with CNS inflammation , 2017, Scientific Reports.

[19]  G. Lachenal,et al.  Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity , 2011, Molecular and Cellular Neuroscience.

[20]  S. Tenzer,et al.  Oligodendrocytes secrete exosomes containing major myelin and stress‐protective proteins: Trophic support for axons? , 2007, Proteomics. Clinical applications.

[21]  F. Lohoff,et al.  Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders. , 2015, Pharmacogenomics.

[22]  T. Whiteside Tumor-Derived Exosomes and Their Role in Cancer Progression. , 2016, Advances in clinical chemistry.

[23]  M. Gratacós,et al.  Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 Are Associated with Panic Disorder and Regulate Several Anxiety Candidate Genes and Related Pathways , 2011, Biological Psychiatry.

[24]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[25]  G. Illei,et al.  The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes , 2012, PloS one.

[26]  Guan Zhang,et al.  A novel cell‐cell communication mechanism in the nervous system: exosomes , 2018, Journal of neuroscience research.

[27]  Diego Diez,et al.  Neuronal exosomes facilitate synaptic pruning by up-regulating complement factors in microglia , 2015, Scientific Reports.

[28]  Jasenka Guduric-Fuchs,et al.  Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types , 2012, BMC Genomics.

[29]  W. Stoorvogel Functional transfer of microRNA by exosomes. , 2012, Blood.

[30]  Haitao Wang,et al.  Visualizing of the cellular uptake and intracellular trafficking of exosomes by live‐cell microscopy , 2010, Journal of cellular biochemistry.

[31]  R. Huganir,et al.  Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression , 2013, Nature Neuroscience.

[32]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[33]  Weiying Zhou,et al.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. , 2014, Cancer cell.

[34]  E. Goetzl,et al.  Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes , 2017, Front. Neurosci..

[35]  R. Pink,et al.  Routes and mechanisms of extracellular vesicle uptake , 2014, Journal of extracellular vesicles.

[36]  Karl J. Friston,et al.  Synaptic Plasticity and Dysconnection in Schizophrenia , 2006, Biological Psychiatry.

[37]  S. Jeong,et al.  A New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer Therapy , 2018, Front. Pharmacol..

[38]  Weian Zhao,et al.  Elucidation of Exosome Migration across the Blood-Brain Barrier Model In Vitro , 2016, Cellular and Molecular Bioengineering.

[39]  U. Wyneken,et al.  Astrocytes at the Hub of the Stress Response: Potential Modulation of Neurogenesis by miRNAs in Astrocyte-Derived Exosomes , 2017, Stem cells international.

[40]  Willem Stoorvogel,et al.  Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry , 2012, Nature Protocols.

[41]  S. Tsukita,et al.  Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.

[42]  Cicek Gercel-Taylor,et al.  MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.

[43]  M. Maes The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. , 2008, Neuro endocrinology letters.

[44]  S. Watson,et al.  Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia , 2004, Biological Psychiatry.

[45]  R. Duman Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression , 2009, Dialogues in clinical neuroscience.

[46]  Jean-Charles Sanchez,et al.  Characterisation of extracellular vesicle-subsets derived from brain endothelial cells and analysis of their protein cargo modulation after TNF exposure , 2017, Journal of extracellular vesicles.

[47]  M. Surette,et al.  Lost in Translation: The Gut Microbiota in Psychiatric Illness , 2015, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[48]  Feng Jiang,et al.  A Comparison of Traditional and Novel Methods for the Separation of Exosomes from Human Samples , 2018, BioMed research international.

[49]  Yongli Guo,et al.  Erratum to “The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China” , 2017, BioMed research international.

[50]  H. Manji,et al.  Cellular Plasticity Cascades in the Pathophysiology and Treatment of Bipolar Disorder , 2008, Neuropsychopharmacology.

[51]  J. Donaldson,et al.  Search for inhibitors of endocytosis , 2012, Cellular logistics.

[52]  J. Pu,et al.  Exosomes Secreted from HEK293-APP Swe/Ind Cells Impair the Hippocampal Neurogenesis , 2017, Neurotoxicity Research.

[53]  J. Launay,et al.  MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants , 2010, Science.

[54]  Improved isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discovery , 2018, Scientific Reports.

[55]  S. Hosseinpour A COMPARATIVE STUDY OF EMOTIONAL DIMENSIONS OF PERSONALITY IN STIMULANTS AND OPIOIDS USERS , 2019 .

[56]  A. Winslow,et al.  Differential Expression of Exosomal microRNAs in Prefrontal Cortices of Schizophrenia and Bipolar Disorder Patients , 2013, PloS one.

[57]  G. Fond,et al.  [Nanopsychiatry. The potential role of nanotechnologies in the future of psychiatry. A systematic review]. , 2013, L'Encephale.

[58]  X. Chen,et al.  Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse , 2015, Scientific Reports.

[59]  Zhiqiang Gao,et al.  Progress in Exosome Isolation Techniques , 2017, Theranostics.

[60]  A. Ashton,et al.  Exosomes: Mechanisms of Uptake , 2015, Journal of circulating biomarkers.

[61]  M. Schachner,et al.  Improvement of neuronal cell survival by astrocyte‐derived exosomes under hypoxic and ischemic conditions depends on prion protein , 2016, Glia.

[62]  Alzheimer's disease beta-amyloid peptides are released in association with exosomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. Lea,et al.  Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study , 2017, Oncotarget.

[64]  Cheuk Y. Tang,et al.  Social stress induces neurovascular pathology promoting depression , 2017, Nature Neuroscience.

[65]  J. Lötvall,et al.  Exosomes purified from a single cell type have diverse morphology , 2016, bioRxiv.

[66]  H. Matsubara,et al.  Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma , 2016, Oncology reports.

[67]  R. Stern,et al.  Higher exosomal tau, amyloid-beta 42 and IL-10 are associated with mild TBIs and chronic symptoms in military personnel , 2018, Brain injury.

[68]  M. Wood,et al.  Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. , 2012, Human molecular genetics.

[69]  T. Liu,et al.  MicroRNA-134 plasma levels before and after treatment for bipolar mania. , 2011, Journal of psychiatric research.

[70]  L. Kheirandish-Gozal,et al.  Exosomes, blood–brain barrier, and cognitive dysfunction in pediatric sleep apnea , 2017 .

[71]  L. Pulliam,et al.  Immune activated monocyte exosomes alter microRNAs in brain endothelial cells and initiate an inflammatory response through the TLR4/MyD88 pathway , 2017, Scientific Reports.

[72]  G. Aghajanian,et al.  Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants , 2016, Nature Medicine.

[73]  C. Frühbeis,et al.  Emerging Roles of Exosomes in Neuron–Glia Communication , 2012, Front. Physio..

[74]  Monique A J van Eijndhoven,et al.  Exosomes , 2010, Annual review of biochemistry.

[75]  B. Blot,et al.  Exosomes secreted by cortical neurons upon glutamatergic synapse activation specifically interact with neurons , 2014, Journal of extracellular vesicles.

[76]  Murray J. Cairns,et al.  Activity-associated miRNA are packaged in Map1b-enriched exosomes released from depolarized neurons , 2014, Nucleic acids research.

[77]  P. Pavlidis,et al.  miR-1202: A Primate Specific and Brain Enriched miRNA Involved in Major Depression and Antidepressant Treatment , 2014, Nature Medicine.

[78]  Neil R. Smalheiser,et al.  Expression of microRNAs and Other Small RNAs in Prefrontal Cortex in Schizophrenia, Bipolar Disorder and Depressed Subjects , 2014, PloS one.

[79]  Richa Gupta,et al.  Exosomes as drug delivery vehicles for Parkinson's disease therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[80]  Saheli Samanta,et al.  Exosomes: new molecular targets of diseases , 2017, Acta Pharmacologica Sinica.

[81]  T. Theoharides,et al.  Extracellular vesicles are increased in the serum of children with autism spectrum disorder, contain mitochondrial DNA, and stimulate human microglia to secrete IL-1β , 2018, Journal of Neuroinflammation.

[82]  R. Sadoul,et al.  Emerging Role of Neuronal Exosomes in the Central Nervous System , 2012, Front. Physio..

[83]  Jing Jing Li,et al.  In vivo evidence for the contribution of peripheral circulating inflammatory exosomes to neuroinflammation , 2018, Journal of Neuroinflammation.

[84]  Aiman S Saab,et al.  Neurotransmitter-Triggered Transfer of Exosomes Mediates Oligodendrocyte–Neuron Communication , 2013, PLoS biology.

[85]  Mariyah Z. Hussain,et al.  MicroRNAs as Biomarkers for Psychiatric Conditions: A Review of Current Research. , 2017, Innovations in clinical neuroscience.

[86]  M. Carabotti,et al.  The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems , 2015, Annals of gastroenterology.

[87]  M. Kubo,et al.  Development of a Highly Sensitive Device for Counting the Number of Disease-Specific Exosomes in Human Sera. , 2018, Clinical chemistry.

[88]  G. Fond,et al.  Nanopsychiatry—The potential role of nanotechnologies in the future of psychiatry: A systematic review , 2013, European Neuropsychopharmacology.

[89]  Andrew F. Hill,et al.  Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles , 2014, Journal of extracellular vesicles.

[90]  E. Goetzl,et al.  Cargo proteins of plasma astrocyte‐derived exosomes in Alzheimer's disease , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[91]  G. Schiera,et al.  Extracellular Vesicle-Associated RNA as a Carrier of Epigenetic Information , 2017, Genes.

[92]  Nela Durisic,et al.  Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons , 2018, Acta Neuropathologica Communications.

[93]  A. Yang,et al.  New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis , 2017, International journal of molecular sciences.

[94]  Lesley Cheng,et al.  Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood , 2014, Journal of extracellular vesicles.

[95]  Tianzhi Yang,et al.  Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio , 2014, Pharmaceutical Research.

[96]  M. Broekman,et al.  Quantification and Size-profiling of Extracellular Vesicles Using Tunable Resistive Pulse Sensing , 2014, Journal of visualized experiments : JoVE.

[97]  T. Davis,et al.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? , 2014, Current pharmaceutical design.

[98]  U. Wyneken,et al.  MiRNAs in Astrocyte-Derived Exosomes as Possible Mediators of Neuronal Plasticity , 2016, Journal of experimental neuroscience.

[99]  R. Johnstone,et al.  Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). , 1987, The Journal of biological chemistry.

[100]  O. Devinsky,et al.  Neuroinflammation and psychiatric illness , 2013, Journal of Neuroinflammation.

[101]  Henrik J Johansson,et al.  Cells release subpopulations of exosomes with distinct molecular and biological properties , 2016, Scientific Reports.

[102]  L. Pulliam,et al.  Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV , 2017, AIDS.

[103]  W. Banks,et al.  Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson’s disease? , 2017, Acta Neuropathologica Communications.

[104]  P. Burgos,et al.  Exosomes as Novel Regulators of Adult Neurogenic Niches , 2016, Front. Cell. Neurosci..

[105]  Mark M. Gergues,et al.  The role of 5-HT receptors in depression , 2017, Molecular Brain.

[106]  S. Ginsberg,et al.  Enhanced exosome secretion in Down syndrome brain - a protective mechanism to alleviate neuronal endosomal abnormalities , 2017, Acta Neuropathologica Communications.

[107]  O. Merkel,et al.  Serotonin stimulates secretion of exosomes from microglia cells , 2015, Glia.

[108]  G. Lachenal,et al.  Exosomes are released by cultured cortical neurones , 2006, Molecular and Cellular Neuroscience.